Conference call regarding Elekta’s Interim Report for May-July 2012/13

Elekta will publish its interim report for May-July 2012/13 on September 4 as
per:

  · The report will be published at approximately 13:00 CET.
  · Elekta will host a telephone conference at 13:45-14:30 CET, with Tomas
Puusepp, President and CEO and Håkan Bergström, CFO.

To take part in the conference call, please dial in 5-10 minutes in advance and
use the access code: 920990

  · UK dial-in number: +44 (0)207 162 00 77
  · US dial-in number: +1 334 323 62 01
  · Swedish dial-in number: +46 (0)8 505 201 10

The telephone conference will also be broadcasted live online (audio only and
without the possibility to ask questions). Please use this link:
http://webeventservices.reg.meeting-stream.com/67238_elekta

For further information, please contact:

Johan Andersson Melbi, Investor Relations Manager, Elekta AB
+46 702 100 451, johan.anderssonmelbi@elekta.com

About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and
resource-efficient solutions that offer confidence to both healthcare providers
and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,300 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker EKTAb.